Publication | Closed Access
A phase 2, randomized, placebo-controlled study of the efficacy and safety of TAK-063 in subjects with an acute exacerbation of schizophrenia
55
Citations
16
References
2018
Year
PsychiatryPsychotic DisorderPsychotropic MedicationPsychopharmacologySchizophreniaPlacebo-controlled StudyAcute ExacerbationSocial SciencesPhase 2MedicinePsychopathology
| Year | Citations | |
|---|---|---|
Page 1
Page 1